The product is labeled as Pravastatin Sodium Tablets, but contains Bupropion Hydrochloride XL tablets
August 15, 2017International Laboratories is recalling one Lot of Pravastatin Sodium Tablets.
The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contains Bupropion Hydrochloride XL 300 mg tablets.
If a consumer mistakenly takes bupropion, common side effects include: nausea, vomiting, dry mouth, headache, constipation, sweating, sore throat, diarrhea, dizziness, restlessness, blurry vision.
Individuals with epilepsy are at higher risk of seizure on bupropion due to it lowering the seizure threshold.
No complaints or reports of medical illnesses or harmful effects have been received to date.
The recalled product was distributed to retail stores in Arkansas, Alabama, Florida, Georgia, Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Missouri, Mississippi, North Carolina, North Dakota, Nebraska, Ohio, Oklahoma, Puerto Rico, South Carolina, South Dakota, Tennessee, Texas, Virginia and Wisconsin.
What to do
Customers who have the recalled product should not open the package or use the contents, but return it to the place of purchase for a full refund.
Consumers with questions may contact International Laboratories at 727-322-7146 Monday Friday, 8 AM 5 PM (EST), or by e-mail at sutka.veselinovic@internationallabs.com.